{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:56:46Z","timestamp":1785322606982,"version":"3.55.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Carbohydrate antigen 19-9 (CA19-9) is a mucin-type glycoprotein tumor marker that is present in trace amounts in normal human tissues, including the pancreas, bile ducts, stomach, colon, and salivary gland epithelium. In pancreatic cancer patients, the positive rate of CA19-9 exceeds 80%. Here, we report a case of hepatocellular jaundice accompanied by a marked elevation in CA19-9 levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 55-year-old female patient was admitted to our hospital with a 6-month history of abdominal distension and dark urine, which had worsened along with scleral jaundice over the past week.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>The initial diagnosis upon admission was \u201cjaundice under investigation.\u201d Laboratory investigations revealed a markedly elevated serum CA19-9 level of 284.8 units per milliliter, raising the possibility of an underlying neoplasm. However, no definite malignant lesions were detected on whole-body positron emission tomography\u2013magnetic resonance imaging. The patient had a long-term history of chronic hepatitis B virus infection with a high viral replication state, suggesting chronic liver injury. Jaundice-related examinations showed elevated levels of total, direct, and indirect bilirubin, markedly abnormal transaminases, and positive urine bilirubin \u2013 findings consistent with the biochemical profile of hepatocellular jaundice. Abdominal computed tomography imaging revealed no biliary dilation, ruling out obstructive jaundice. The absence of anemia or abnormal hemolysis-related parameters argued against hemolytic jaundice. Although tumor markers (CA19-9 and alpha-fetoprotein) were transiently elevated, the absence of malignant masses on imaging and the subsequent normalization of CA19-9 levels following treatment led to the exclusion of malignancy-associated jaundice. The final diagnosis was confirmed as hepatocellular jaundice associated with viral hepatitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient received active antiviral therapy, liver-protective treatment, and symptomatic supportive care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient\u2019s jaundice significantly subsided, and liver function parameters gradually improved. The patient was discharged after meeting the relevant criteria. A 6-month follow-up examination showed that CA19-9 levels had essentially returned to the normal range.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case demonstrates a significant and reversible elevation of CA19-9 in benign hepatocellular jaundice, the dynamics of which correlated with disease activity. It serves as a critical reminder that CA19-9 can be a misleading biomarker for malignancy in this clinical scenario.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000046994","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:02:31Z","timestamp":1769191351000},"page":"e46994","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Hepatocellular jaundice with abnormally high CA19-9: A case report"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1061-736X","authenticated-orcid":false,"given":"Yangqing","family":"Cui","sequence":"first","affiliation":[{"name":"The Third Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijing","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Third Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Huang","sequence":"additional","affiliation":[{"name":"The Third Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Feng","sequence":"additional","affiliation":[{"name":"The Third Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunqun","family":"Chen","sequence":"additional","affiliation":[{"name":"The Third Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260610","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41576-022-00553-x","article-title":"Spatial biology of cancer evolution.","volume":"24","author":"Seferbekova","year":"2023","journal-title":"Nat Rev Genet"},{"key":"R2-20260610","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","article-title":"Cancer treatments: past, present, and future.","volume":"286\u2013287","author":"Sonkin","year":"2024","journal-title":"Cancer Genet"},{"key":"R3-20260610","doi-asserted-by":"crossref","first-page":"289","DOI":"10.21147\/j.issn.1000-9604.2025.02.12","article-title":"Different strategies for cancer treatment: targeting cancer cells or their neighbors?","volume":"37","author":"Liu","year":"2025","journal-title":"Chin J Cancer Res"},{"key":"R4-20260610","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40792-023-01648-1","article-title":"A case of acute cholecystitis with abnormally high CA19-9.","volume":"9","author":"Oinuma","year":"2023","journal-title":"Surg Case Rep"},{"key":"R5-20260610","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2169\/internalmedicine.2597-23","article-title":"A significant increase in the serum carbohydrate antigen 19-9 level accompanied by acute cholecystitis and choledocholithiasis: a case report and review of the literature.","volume":"63","author":"Kawaguchi","year":"2024","journal-title":"Intern Med"},{"key":"R6-20260610","first-page":"e57469","article-title":"Carbohydrate antigen (CA 19-9) surge: unraveling the enigma of elevated levels in the setting of benign etiologies.","volume":"16","author":"Ansari","year":"2024","journal-title":"Cureus"},{"key":"R7-20260610","doi-asserted-by":"crossref","first-page":"e931819","DOI":"10.12659\/AJCR.931819","article-title":"Elevation of CA 19-9 in Mirizzi Syndrome in the absence of malignancy: a case report.","volume":"22","author":"Moshref","year":"2021","journal-title":"Am J Case Rep"},{"key":"R8-20260610","doi-asserted-by":"crossref","first-page":"122605","DOI":"10.1016\/j.biomaterials.2024.122605","article-title":"BNCT pancreatic cancer treatment strategy with glucose-conjugated boron drug.","volume":"309","author":"Fujimoto","year":"2024","journal-title":"Biomaterials"},{"key":"R9-20260610","doi-asserted-by":"crossref","first-page":"10013","DOI":"10.1021\/acsnano.4c16698","article-title":"machine learning-aided identification of fecal extracellular vesicle microRNA signatures for noninvasive detection of colorectal cancer.","volume":"19","author":"Zhang","year":"2025","journal-title":"ACS Nano"},{"key":"R10-20260610","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/jmri.29747","article-title":"Evaluation of occult liver metastases in pancreatic adenocarcinoma by diffusion-weighted related magnetic resonance imaging.","volume":"62","author":"Wang","year":"2025","journal-title":"J Magn Reson Imaging"},{"key":"R11-20260610","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/j.gastro.2023.02.044","article-title":"A liquid biopsy signature for the early detection of gastric cancer in patients.","volume":"165","author":"Guo","year":"2023","journal-title":"Gastroenterology"},{"key":"R12-20260610","doi-asserted-by":"crossref","first-page":"1649080","DOI":"10.3389\/fonc.2025.1649080","article-title":"Case report: sequential PTCD and biliary seed stent combined with targeted-immunotherapy for advanced pancreatic cancer with malignant obstructive jaundice: a multidisciplinary approach.","volume":"15","author":"Li","year":"2025","journal-title":"Front Oncol"},{"key":"R13-20260610","first-page":"403","article-title":"Elevated carbohydrate antigen 19-9 following Helicobacter suis gastritis and normalisation after eradication: first case report and review of the literature.","volume":"85","author":"Capirchio","year":"2022","journal-title":"Acta Gastroenterol Belg"},{"key":"R14-20260610","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMcpc2402493","article-title":"Case 31-2024: a 37-year-old man with fever, myalgia, jaundice, and respiratory failure.","volume":"391","author":"Hillmann","year":"2024","journal-title":"N Engl J Med"},{"key":"R15-20260610","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1053\/j.gastro.2020.10.006","article-title":"COVID-19 and jaundice.","volume":"160","author":"Weaver","year":"2021","journal-title":"Gastroenterology"},{"key":"R16-20260610","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1445-2197.2006.03794.x","article-title":"Hepatocellular carcinoma presenting with obstructive jaundice.","volume":"76","author":"Lai","year":"2006","journal-title":"ANZ J Surg"},{"key":"R17-20260610","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1148\/123.2.429","article-title":"Ultrasonography in obstructive jaundice.","volume":"123","author":"Malini","year":"1977","journal-title":"Radiology"},{"key":"R18-20260610","first-page":"e15937","article-title":"Clinical and virological features of acute hepatic exacerbations in patients with chronic hepatitis B virus infection.","volume":"13","author":"Bestas","year":"2021","journal-title":"Cureus"},{"key":"R19-20260610","doi-asserted-by":"crossref","first-page":"2374289519877546","DOI":"10.1177\/2374289519877546","article-title":"Educational case: hepatitis B virus.","volume":"6","author":"Nickens","year":"2019","journal-title":"Acad Pathol"},{"key":"R20-20260610","first-page":"22066","article-title":"Jaundice in the adult patient.","volume":"119","author":"Kourie","year":"2022","journal-title":"Lakartidningen"},{"key":"R21-20260610","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1016\/j.cell.2021.10.001","article-title":"Glycogen accumulation and phase separation drives liver tumor initiation.","volume":"184","author":"Liu","year":"2021","journal-title":"Cell"},{"key":"R22-20260610","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.stem.2022.04.008","article-title":"The spatiotemporal program of zonal liver regeneration following acute injury.","volume":"29","author":"Ben-Moshe","year":"2022","journal-title":"Cell Stem Cell"},{"key":"R23-20260610","doi-asserted-by":"crossref","first-page":"e71074","DOI":"10.1002\/fsn3.71074","article-title":"Exocarpium citri grandis ameliorates metabolic disorders by inhibiting inflammatory responses and NLRP3 Inflammasome activation.","volume":"13","author":"Chen","year":"2025","journal-title":"Food Sci Nutr"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:02:27Z","timestamp":1781085747000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046994","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"2025-07-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}